Caris Life Sciences Inc.
CAI | NASDAQ
$33.85
-$0.48 (-1.40%)
Nov 2, 2026, 10:08 AM ET · Market open
Market Data
Market Cap $9.57B
Enterprise Value $9.36B
Beta 0.68
Average Volume 4.53M
Shares Outstanding (Diluted) 282.89M
Shares Change YoY 2.5%
Institutional Ownership 54.58%
Exchange NASDAQ
ISIN US1421521071
Price Performance
Price Change 1M 19.6%
Price Change 3M 107.4%
Price Change 6M 81.1%
Price Change YTD 25.5%
Price Change 1Y 13.1%
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 14.5%
1Y CAGR (ann.) 16.6%
5Y CAGR (ann.) N/A
All-Time CAGR 16.1%
Valuation
PE Ratio 95.36
Forward PE 93.28
PEG Ratio 0.34
Forward PEG -0.83
PS Ratio 9.81
Forward PS 7.90
PB Ratio 16.40
P/FCF Ratio 66.25
P/Adj. FCF Ratio 119.25
P/OCF Ratio 48.35
EV/Sales 9.46
EV/EBIT 61.63
EV/EBITDA 54.22
EV/FCF 63.92
Earnings Yield 1.1%
FCF Yield 1.5%
Adj. FCF Yield 0.8%
Financial Health
Net Cash $399.96M
Total Debt $452.4M
Cash & Short-Term Investments $793.12M
Total Assets $1.23B
Current Ratio 5.53
Quick Ratio 4.88
Debt / Equity Ratio 0.76
Debt / EBITDA 2.62
Debt / FCF 3.09
OCF / Debt 0.45
Interest Coverage 3.27
Altman Z-Score 8.28
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 69.7%
Operating Profit Margin 15.5%
EBITDA Margin 17.4%
Net Profit Margin 10.6%
FCF Margin 14.8%
Adj. FCF Margin 8.2%
SBC / Revenue 6.6%
SBC Impact (per share) -44.5%
Returns
Return on Assets 8.6%
Return on Equity 18.8%
Return on Invested Capital 14.7%
Return on Capital Employed 14.8%
Return on Tangible Assets 8.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 48.9%
Revenue CAGR 5Y 17.2%
Revenue CAGR 10Y 16.5%
EPS CAGR 3Y -53.8%
EPS CAGR 5Y -38.6%
EPS CAGR 10Y -18.4%
FCF CAGR 3Y 319.0%
FCF CAGR 5Y 37.8%
FCF CAGR 10Y 17.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 17.5%
Revenue Growth Next 3Y 18.2%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.03
EPS Growth Est (next Q) -64.8%
Revenue Est (next Q) $255.37M
Revenue Growth Est (next Q) 17.8%
Fair Value Estimates
Graham Number $4.11
Graham Upside -88.0%
Lynch Fair Value $1.80
Lynch Upside -94.8%
Price Target $28.50
Price Target Upside -17.0%
Cash Flow
Operating Cash Flow $201.43M
Free Cash Flow $146.49M
Adj. Free Cash Flow $81.38M
FCF Per Share $0.52
OCF Per Share $0.71
OCF/S Ratio 20.4%
Income Statement
Revenue $989.61M
Gross Profit $689.36M
Operating Income $153.26M
EBITDA $172.69M
Net Income $105.14M
EPS (Diluted) $0.36
Revenue / Employee $536.08K
Profit / Employee $56.95K
Employees 1,846
Add to Watchlist
Select watchlists to add or remove CAI